Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -486.46 | -36.47 |
PEG Ratio (TTM) | -6.65 | 1.88 |
P/S Ratio (TTM) | 3.30 | 2.23 |
P/B Ratio (TTM) | 3.47 | 0.67 |
P/FCF Ratio (TTM) | 150.34 | 34.78 |
Price to 5YR AVG Earnings Ratio | N/A | -74.56 |
Price to 5YR AVG FCF Ratio | N/A | 8.94 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.33% | 1.83% |
ROE (TTM) | -1.00% | 3.61% |
Net Profit Margin (TTM) | -0.63% | 3.80% |
ROIC 5YR AVG | N/A | -0.58% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 346.49% | -0.51% | N/A |
Revenue | 8.15% | 26.81% | N/A |
Net Income | 347.98% | -0.65% | N/A |
Cash Flow | 170.05% | 58.79% | N/A |
Health (47%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.62 | 1.03 |
Quick Ratio (TTM) | 0.77 | 0.72 |
D/E Ratio (TTM) | 0.55 | 0.96 |
Interest Coverage (TTM) | 1.14 | 4.92 |
Piotroski F-Score | 5 | 5 |
Altman Z-Score | 2.61 | 1.96 |
LTL to 5YR AVG FCF | N/A | -0.62 |
Shares Outstanding Growth 5YR AVG | N/A | 8.44% |